72 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor
Zihan Chen ... Lei Wang
Published: May 13, 2025 Explor Target Antitumor Ther. 2025;6:1002315
This article belongs to the special issue Novel Biomarkers in the Immunotherapy Era
Open Access
Review
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
David Sinclair Thomas Junior ... Yong-Jie Lu
Published: May 13, 2025 Explor Target Antitumor Ther. 2025;6:1002314
Open Access
Review
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M Naffaa ... Valiko Begiashvili
Published: April 27, 2025 Explor Target Antitumor Ther. 2025;6:1002313
Open Access
Review
Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Mathan Muthu Chinakannu Marimuthu ... Hitesh Chopra
Published: April 26, 2025 Explor Target Antitumor Ther. 2025;6:1002312
Open Access
Review
Viral infections and immune modulation in bladder cancer: implications for immunotherapy
Lívia Bitencourt Pascoal ... Leonardo O. Reis
Published: April 24, 2025 Explor Target Antitumor Ther. 2025;6:1002311
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Review
Modulation of anti-tumour immunity by XPO1 inhibitors
Jack G. Fisher ... Matthew D. Blunt
Published: April 23, 2025 Explor Target Antitumor Ther. 2025;6:1002310
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Case Report
Eosinophil cytolysis with or without ETosis in four cases of human gastric cancer: a comparative ultrastructural study
Rosario Caruso ... Luciana Rigoli
Published: April 21, 2025 Explor Target Antitumor Ther. 2025;6:1002309
Open Access
Review
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen ... Fahima Dilnawaz
Published: April 10, 2025 Explor Target Antitumor Ther. 2025;6:1002308
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Review
Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances
Albert Jang, Jason R. Brown
Published: April 07, 2025 Explor Target Antitumor Ther. 2025;6:1002307
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Review
Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review
Majid Banimohammad ... Hamidreza Pazoki-Toroudi
Published: April 02, 2025 Explor Target Antitumor Ther. 2025;6:1002306
This article belongs to the special issue Predictive and Prognostic Biomarkers in Cancer: Towards the Precision Medicine Era
Open Access
Short Communication
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma
Ilya Tsimafeyeu ... Mark Gluzman
Published: April 01, 2025 Explor Target Antitumor Ther. 2025;6:1002305
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Review
Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
Anna Di Spirito ... Lorenzo Mortara
Published: March 31, 2025 Explor Target Antitumor Ther. 2025;6:1002304
This article belongs to the special issue Novel Insights into Immunotherapy Targeting Tumor Microenvironment in Cancer
Open Access
Review
State-of-the-art photodynamic therapy for malignant gliomas: innovations in photosensitizers and combined therapeutic approaches
Bruno A. Cesca ... Luis E. Ibarra
Published: March 28, 2025 Explor Target Antitumor Ther. 2025;6:1002303
Open Access
Review
Advances in adoptive cell therapies in small cell lung cancer
Eljie Isaak Bragasin ... Robert Hsu
Published: March 26, 2025 Explor Target Antitumor Ther. 2025;6:1002302
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Review
Bladder cancer biomarkers
Dominik Godlewski ... David Aebisher
Published: March 25, 2025 Explor Target Antitumor Ther. 2025;6:1002301
Open Access
Meta-Analysis
A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab
Daniel Thomas Jones ... Thura Win Htut
Published: March 19, 2025 Explor Target Antitumor Ther. 2025;6:1002300
Open Access
Review
Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Vittore Cereda, Mario Rosario D’Andrea
Published: March 18, 2025 Explor Target Antitumor Ther. 2025;6:1002299
Open Access
Review
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov ... Natalia V. Mitiushkina
Published: March 17, 2025 Explor Target Antitumor Ther. 2025;6:1002298
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Review
Metabolic mechanisms of immunotherapy resistance
Luis Cabezón-Gutiérrez ... Vilma Pacheco-Barcia
Published: March 13, 2025 Explor Target Antitumor Ther. 2025;6:1002297
This article belongs to the special issue Novel Biomarkers in the Immunotherapy Era
Open Access
Review
Immunotherapy in cervical cancer: an innovative approach for better treatment outcomes
Treshita Dey, Sushma Agrawal
Published: March 02, 2025 Explor Target Antitumor Ther. 2025;6:1002296
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Previous